GlaxoSmithKline

GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and employs over 4000 people. Globally, we are a £ 27.4 billion, leading, research-based healthcare and pharmaceutical company. In India, we are one of the market leaders. At GSK, our mission is to improve the quality of life by enabling people to do more, feel better and live longer. This mission drives us to make a real difference to the lives of millions of people with our commitment to effective healthcare solutions.

Post: Asst. Manager - Manufacturing

National Institute of Nutrition (NIN) was founded by Sir Robert McCarrison in the year 1918 as ‘Beri-Beri’ Enquiry Unit in a single room laboratory at the Pasteur Institute, Coonoor, Tamil Nadu. Within a short span of seven years, this unit blossomed into a "Deficiency Disease Enquiry" and later in 1928, emerged as full-fledged "Nutrition Research Laboratories" (NRL) with Dr. McCarrison as its first Director. It was shifted to Hyderabad in 1958.

The Bhopal Memorial Hospital and Research Centre (BMHRC), set up to provide super-speciality treatment to the Bhopal gas tragedy survivors and also to carry out research on long term effects of methyl-iso-cyanate (MIC), has become a hot spot for conducting clinical trials on untested drugs by the multinational pharma companies, it is reliably learnt.

The multinational drug company GlaxoSmithKline (GSK), which had run an advertisement blitzkrieg in several national newspapers in the country on cervical cancer vaccine late last year in gross violation of Drugs and Cosmetics Act, 1940 and Drugs and Magical Remedies Act 1954, has been completely absolved of any irregularities by the drug controller general of India (DCGI) Dr Surinder Singh, it is learnt.

The addition of a glucagonlike peptide-1 (GLP-1) agonist in patients with inadequate glycemic control when treated with metformin alone resulted in significantly larger reductions in HbA1c levels when compared with the addition of a dipeptidyl peptidase-4 (DPP-4) inhibitor, a new study has shown.

In a novel agreement, two global pharma majors have planned to make available their top-selling pneumonia vaccines at one-eighth of the market rates to save lives of poor children in developing countries.

Every day, 4,384 people, mostly children below the age of five, die due to preventable pneumococcal diseases, primarily pneumonia and meningitis. Most of these deaths, 1.6 million in a year, occur in some of the world’s poorest countries.

Singapore, Mar 30, 2010: A new and simple test to help patients cope better with COPD, a chronic lung disease is being launched to local medical practitioners of Singapore. Experts now hope the COPD Assessment Test (CAT) that was funded by GlaxoSmithKline (GSK) and is freely available for use, will be a significant breakthrough in efforts to reduce the burden of one of the world’s most debilitating diseases.

March 22, 2010 — The US Food and Drug Administration (FDA) announced today viral contamination of GlaxoSmithKline's Rotarix vaccine. The agency is recommending that doctors stop using the vaccine until further investigations are complete.

An independent academic research team testing the product recently identified porcine circovirus 1 in the vaccine and notified regulators.